Baton Rouge, Louisiana, United States
Accomplished Vice President of New Business Development (Mergers & Acquisitions, Divestments, Strategic Alliances), Corporate Strategy, & Global Marketing with more than 24 years of medical device, life science, and pharmaceutical experience. Extensive track record of success in a variety of senior management, global marketing (upstream & downstream), product management, business development, strategy, and sales positions. Recognized for effectively leading teams and developing people, creating and executing strategic business plans, developing and executing successful new product launch campaigns, identifying, assessing, and executing new business development opportunities including acquisition, divestments, licensing, and distribution opportunities, managing P&L, identifying and collaborating with clinical studies efforts and regulatory to gain additional product indications and approvals, and effectively leading physician and sales training.
Responsibility includes Mergers & Acquisitions, Divestments, Strategic Alliances for the Acute Care Therapies (ACT) Business Unit with annual turnover ~ $2 Billion USD. ACT consists of market leading and life saving therapies and solutions for Peripheral and Coronary Interventions, Vascular and AV Dialysis Access Surgery, Cardiac & Thoracic Surgery, Cardiac Assist, Critical Care, Advanced Monitoring, CardioPulmonary, and Digital Health Solutions.
Prytime Medical Devices, Inc., an innovative medical device company, designs, develops, and commercializes minimally invasive solutions for hemorrhage control.
Gulf South Angels formerly known as NO/LA Angel Network is a group of of accredited investors from New Orleans and throughout Louisiana & Mississippi who work together to evaluate, fund, and nurture early-stage companies with high growth potential.
Responsible for leading, managing, and directing MAQUET Medical Systems New Business Development, Strategy, Global Marketing, Product Management, and Training Initiatives. The divisions includes medical devices that serve the peripheral interventional, coronary interventional, vascular sugery, cardiothoracic surgery, cardiac surgery, and dialysis markets. • October 2014: Lead M&A activity, New Business Development, and Global Marketing Operations for the Vascular Systems Group • March 2014: Lead Marketing Operations with P&L management for (CardioVascular Interventions, CardioThoracic Systems, Cardiac Assist, Critical Care, Cardiac Surgery, CardioPulmonary, Surgical Workplaces) • January 2014: Lead Marketing Operations with P&L management for Vascular Systems Group
Responsible for leading, managing, and directing Atrium Medical's Global Marketing, Product Management, New Business Development (Acquisition and Licensing Targets), Physician & Sales Training, Strategy Initiatives, and OEM Operations for the CardioVascular Interventions Division. The CVI division includes medical devices that serve the peripheral interventional, coronary interventional, vascular sugery, cardiothoracic surgery, and dialysis markets. • Strong contributor to the bottom line by helping lead the flagship division in the company which accounts for 56% of the company’s sales and 65% of the company’s profit • Achieved 16% revenue growth for 2013 vs 2012 and exceeded EBITA targets • Helped grow the CVI Division 357% from 2006 to 2012 • Achieved 22% revenue growth for 2012 vs 2011 and exceeded EBITA targets Received the CEO Excellence Award
Responsible for Sales and Promotions of pharmaceutical therapies that targeted the anti-infective, pain management, depression/anxiety, and diabetes markets into Teaching Hospitals, DOD facilities, LTC facilities, and Group Physician Practices. Received the Vice President's Cabinet Award for top sales performance. Received multiple regional awards for sales performance, leadership, and innovative strategy development.